Immune-related adverse events and clinical outcomes in patients with solid tumors treated with adebrelimab: a real-world exploratory study
Objective To investigate the association between treatment efficacy and immune-related adverse events (irAEs) in patients with solid malignancies receiving adebrelimab. Methods Clinical data from 46 patients with solid tumors who received adebrelimab between June 2023 and March 2026 were retrospectively collected. Pati...